Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D'Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Opie LH, Rackley CE, Apstein CS, Udelson JE.

JAMA. 2012 May 9;307(18):1925-33. doi: 10.1001/jama.2012.426. Epub 2012 Mar 27.

2.

Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials.

Jin PY, Zhang HS, Guo XY, Liang WF, Han QF.

BMC Cardiovasc Disord. 2014 Nov 25;14:169. doi: 10.1186/1471-2261-14-169. Review.

4.

Glucose-insulin-potassium therapy in the era of coronary revascularization.

Leos CL, Griego JE, Anderson JR.

Cardiol Rev. 2005 Sep-Oct;13(5):266-70. Review.

PMID:
16106190
5.

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.

Tricoci P, Newby LK, Hasselblad V, Kong DF, Giugliano RP, White HD, Théroux P, Stone GW, Moliterno DJ, Van de Werf F, Armstrong PW, Prabhakaran D, Rasoul S, Bolognese L, Durand E, Braunwald E, Califf RM, Harrington RA.

Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):448-58. doi: 10.1161/CIRCOUTCOMES.110.960294. Epub 2011 Jun 28. Review.

6.

Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials.

Navarese EP, Buffon A, Andreotti F, Gurbel PA, Kozinski M, Kubica A, Musumeci G, Cremonesi A, Tavazzi L, Kubica J, Castriota F.

Atherosclerosis. 2012 May;222(1):1-7. doi: 10.1016/j.atherosclerosis.2011.11.001. Epub 2011 Nov 9. Review.

PMID:
22153149
7.

Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Goyal A, Nerenberg K, Gerstein HC, Umpierrez G, Wilson PW.

Diab Vasc Dis Res. 2008 Nov;5(4):276-84. doi: 10.3132/dvdr.2008.040. Review.

8.

Low-dose of oral factor Xa inhibitors in patients with a recent acute coronary syndrome: a systematic review and meta-analysis of randomized trials.

Obonska K, Navarese EP, Lansky A, Tarantini G, Rossini R, Kozinski M, Musumeci G, Di Pasquale G, Górny B, Szczesniak A, Kowalewski M, Gurbel PA, Kubica J.

Atherosclerosis. 2013 Aug;229(2):482-8. doi: 10.1016/j.atherosclerosis.2013.04.022. Epub 2013 Apr 24. Review.

PMID:
23672879
9.

Hyperglycaemia in Acute Coronary Syndromes: Management of Hyperglycaemia in People with Acute Coronary Syndromes.

Centre for Clinical Practice at NICE (UK).

London: National Institute for Health and Clinical Excellence (UK); 2011 Oct.

10.

Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction.

van der Horst IC, Zijlstra F.

Neth Heart J. 2005 Jun;13(6):233-238. Review.

Items per page

Supplemental Content

Write to the Help Desk